Mary Ellen Rybak
About
In The Last Decade
Mary Ellen Rybak
15 papers receiving 554 citations
Peers
Comparison fields: 5 of 61
- Hematology 294
- Molecular Biology 229
- Oncology 169
- Pulmonary and Respiratory Medicine 104
- Genetics 89
Countries citing papers authored by Mary Ellen Rybak
This map shows the geographic impact of Mary Ellen Rybak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellen Rybak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellen Rybak more than expected).
Fields of papers citing papers by Mary Ellen Rybak
This network shows the impact of papers produced by Mary Ellen Rybak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellen Rybak. The network helps show where Mary Ellen Rybak may publish in the future.
Co-authorship network of co-authors of Mary Ellen Rybak
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ellen Rybak. A scholar is included among the top collaborators of Mary Ellen Rybak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ellen Rybak. Mary Ellen Rybak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 367 | |
| 3 | 3 | |
| 4 | 15 | |
| 5 | 26 | |
| 6 | 2 | |
| 7 | 57 | |
| 8 | 24 | |
| 9 | 2 | |
| 10 | 4 | |
| 11 | Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652. | 5 |
| 12 | 3 | |
| 13 | 12 | |
| 14 | 1 | |
| 15 | 59 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.